CEO, US Medical Lab
Branka Matevich is the CEO of US Med Sci IN, a regional clinical laboratory. In this role, Branka oversees the Company’s day-to-day operations and planning for future growth. She honed her skills in leadership and management while working in other companies in the healthcare industry. She had developed skills in both operations and sales/growth. Former positions include Strategy and Solutions at Quest; Director of Sales and Marketing at Advocate Health Care; Director Business Development (Sales Leader) at ACL Laboratories; and TQS Sales Manager at Boston Biomedica, Inc. She has an MBA and a Masters in Science from Loyola University.
Branka is speaking at
The opioid crisis has had a huge impact in our country. Clinical laboratories are often times at the front of helping to address this crisis. In our current healthcare environment, it has become almost impossible to accomplish the goal of helping in-patient treatment because of Draconian rules in place from payors. Additionally, there are other pressures on laboratories that make it almost impossible to work effectively to address this public health crisis. The purpose of this topic is to discuss the challenges faced by laboratories today and recommendations for potential solutions. We will also look at logic that our lab uses for drug testing orders that meet CMS requirements.
DocumentsThe Opioid Crisis
Add to my calendar
Create your personal schedule through the official app, Whova!Get Started